CALLIDITAS THERAPEUTICS AB SER'B'NPV earnings per share and revenue

0A5R earnings per share for the last quarter are -1.70 SEK whereas the estimation was -0.97 SEK which accounts for -74.95% surprise. Företagets omsättning för samma period uppgår till 350.00 M SEK trots den uppskattade siffran 372.07 M SEK. Estimated earnings per share for the next quarter are -0.13 SEK, and revenue is expected to reach 440.41 M SEK. Also watch annual changes over time to get a bigger picture of 0A5R earnings per share and revenue dynamics.